
Lantheus Holdings LNTH
$ 103.99
3.74%
Quarterly report 2026-Q1
added 05-07-2026
Country |
|
IPO year |
2015 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
67.5 M |
Market Cap[1] |
$ 7.02 B |
EBITDA (LTM) |
$ 374 M |
P/E (LTM) |
20.45 |
P/S (LTM) |
4.06 |
EPS (LTM) |
4.45 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 203.75 | -0.01 % | $ 22.6 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 89.67 | 1.62 % | $ 4.19 B | Nasdaq Global Select Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 4.7 | -3.69 % | $ 6.25 M | Nasdaq Capital Market | ||
|
Fulgent Genetics
FLGT
|
$ 18.8 | -0.69 % | $ 579 M | Nasdaq Global Market | ||
|
Castle Biosciences
CSTL
|
$ 21.11 | 0.14 % | $ 612 M | Nasdaq Global Market,SPB | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
ICON Public Limited Company
ICLR
|
$ 148.67 | 2.82 % | $ 11.7 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 164.19 | 1.06 % | $ 25.4 B | Nasdaq Global Select Market,SPB | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Guardant Health
GH
|
$ 131.81 | 0.85 % | $ 16.5 B | Nasdaq Global Select Market,SPB | ||
|
CareDx, Inc
CDNA
|
$ 24.05 | 2.51 % | $ 1.28 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Interpace Biosciences
IDXG
|
$ 1.65 | -6.41 % | $ 7.3 M | Nasdaq Global Select Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Pacific Biosciences of California
PACB
|
$ 1.36 | -1.09 % | $ 408 M | Nasdaq Global Select Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 188.58 | 1.32 % | $ 9.35 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Medpace Holdings
MEDP
|
$ 475.73 | 2.15 % | $ 13.7 B | Nasdaq Global Select Market,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Mettler-Toledo International
MTD
|
$ 1 139.74 | 0.59 % | $ 23.5 B | NYSE,SPB | ||
|
NeoGenomics
NEO
|
$ 11.4 | 1.06 % | $ 1.46 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.64 | 4.85 % | $ 430 M | Nasdaq Global Select Market,SPB | ||
|
National Research Corporation
NRC
|
$ 18.98 | -10.81 % | $ 425 M | Nasdaq Global Select Market | ||
|
Natera
NTRA
|
$ 220.54 | 1.87 % | $ 30.2 B | Nasdaq Global Select Market,SPB | ||
|
Personalis
PSNL
|
$ 9.34 | -2.81 % | $ 834 M | Nasdaq Global Select Market | ||
|
Koninklijke Philips N.V.
PHG
|
$ 26.24 | 2.14 % | $ 24.9 B | NYSE | ||
|
Senseonics Holdings
SENS
|
$ 7.42 | 1.64 % | $ 310 M | NYSE American | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | ||
|
Twist Bioscience Corporation
TWST
|
$ 71.83 | 5.99 % | $ 4.3 B | Nasdaq Global Select Market,SPB | ||
|
Biomerica
BMRA
|
$ 2.08 | 2.97 % | $ 4.78 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 265.04 | -1.34 % | $ 22.1 B | NYSE,SPB | ||
|
Thermo Fisher Scientific
TMO
|
$ 476.57 | -1.19 % | $ 180 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.68 | -1.47 % | $ 244 M | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.3 | 1.36 % | $ 2.02 B | Nasdaq Global Select Market,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.